35 results
8-K
EX-99.3
TXMD
TherapeuticsMD Inc
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
to highest decile physicians for all products Focus representatives on solution selling Provide direction, tools and evaluations to create sustainable
8-K/A
EX-99.1
TXMD
TherapeuticsMD Inc
16 Nov 21
Results of Operations and Financial Condition
6:30am
and tools that are designed to result in sustainable, consistent growth. I'm excited for the opportunities for success and recognize there's still much
8-K
EX-99.1
3bn 3ztls77cqjc
25 Jan 13
Special Note Regarding Forward-Looking Statements
12:00am
8-K
ses110
11 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K/A
u3iprge3qmsh wol42
22 Nov 11
Entry into a Material Definitive Agreement
12:00am
424B7
hdsjwsqv4 ekn
21 Mar 14
Prospectus with selling stockholder info
12:00am
424B5
jyujj
7 Mar 13
Prospectus supplement for primary offering
12:00am
424B5
91pz1wi95syw2dr nh
15 Mar 13
Prospectus supplement for primary offering
12:00am